When VEGF and VEGF-C were investigated as major ligands of RAGE upon human recombinant HMGB1 administration in OSCC cell lines, it was shown that VEGF secretion was significantly upregulated in RAGE-positive tumor cells in a dose-dependent manner. The gene discussed is HMGB1; the disease is neoplasm.